<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20030000130A1-20030102-C00001.CDX SYSTEM "US20030000130A1-20030102-C00001.CDX" NDATA CDX>
<!ENTITY US20030000130A1-20030102-C00001.MOL SYSTEM "US20030000130A1-20030102-C00001.MOL" NDATA MOL>
<!ENTITY US20030000130A1-20030102-C00001.TIF SYSTEM "US20030000130A1-20030102-C00001.TIF" NDATA TIF>
<!ENTITY US20030000130A1-20030102-C00002.CDX SYSTEM "US20030000130A1-20030102-C00002.CDX" NDATA CDX>
<!ENTITY US20030000130A1-20030102-C00002.MOL SYSTEM "US20030000130A1-20030102-C00002.MOL" NDATA MOL>
<!ENTITY US20030000130A1-20030102-C00002.TIF SYSTEM "US20030000130A1-20030102-C00002.TIF" NDATA TIF>
<!ENTITY US20030000130A1-20030102-C00003.CDX SYSTEM "US20030000130A1-20030102-C00003.CDX" NDATA CDX>
<!ENTITY US20030000130A1-20030102-C00003.MOL SYSTEM "US20030000130A1-20030102-C00003.MOL" NDATA MOL>
<!ENTITY US20030000130A1-20030102-C00003.TIF SYSTEM "US20030000130A1-20030102-C00003.TIF" NDATA TIF>
<!ENTITY US20030000130A1-20030102-C00004.CDX SYSTEM "US20030000130A1-20030102-C00004.CDX" NDATA CDX>
<!ENTITY US20030000130A1-20030102-C00004.MOL SYSTEM "US20030000130A1-20030102-C00004.MOL" NDATA MOL>
<!ENTITY US20030000130A1-20030102-C00004.TIF SYSTEM "US20030000130A1-20030102-C00004.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20030000130</doc-number>
<kind-code>A1</kind-code>
<document-date>20030102</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10093111</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020307</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C10L005/00</ipc>
</classification-ipc-primary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>044</class>
<subclass>275000</subclass>
</uspc>
</classification-us-primary>
</classification-us>
<title-of-invention>Candle wax stabilized with piperazinones</title-of-invention>
</technical-information>
<continuity-data>
<continuations>
<continuation-in-part-of>
<parent-child>
<child>
<document-id>
<doc-number>10093111</doc-number>
<kind-code>A1</kind-code>
<document-date>20020307</document-date>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09824194</doc-number>
<document-date>20010402</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>PENDING</parent-status>
</parent-child>
</continuation-in-part-of>
</continuations>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Mervin</given-name>
<middle-name>G.</middle-name>
<family-name>Wood</family-name>
</name>
<residence>
<residence-us>
<city>Poughquag</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Andrea</given-name>
<middle-name>R.</middle-name>
<family-name>Smith</family-name>
</name>
<residence>
<residence-us>
<city>Wingdale</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Deborah</given-name>
<family-name>Judd</family-name>
</name>
<residence>
<residence-us>
<city>Poughkeepsie</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>JoAnn Villamizar</name-1>
<name-2>Ciba Specialty Chemicals Corporation</name-2>
<address>
<address-1>540 White Plains Road</address-1>
<address-2>P.O. Box 2005</address-2>
<city>Tarrytown</city>
<state>NY</state>
<postalcode>10591-9005</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">White, dyed, dipped, unscented and/or scented candle wax is effectively stabilized against discoloration and fading by the incorporation therein of a triazine-based piperazinone stabilizer in combination with a UV absorber and/or an antioxidant. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This is a continuation-in-part of U.S. application Ser. No. 09/824,194, filed Apr. 02, 2001.</paragraph>
</cross-reference-to-related-applications>
<summary-of-invention>
<paragraph id="P-0002" lvl="0"><number>&lsqb;0002&rsqb;</number> The instant invention pertains to white, dyed, dipped, unscented and/or scented candle wax which is effectively stabilized against discoloration and fading by the incorporation therein of a piperazinone in combination with a UV absorber and/or an antioxidant. </paragraph>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> Candles have been known for many centuries going back to the eighth century B.C. The nature of candles is described in Ullmann&apos;s Encyclopedia of Industrial Chemistry, Volume A5 at pages 29-30 where it is seen that candles are made from paraffin, beeswax and stearin as basic materials, and where a host of additives may also be present. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> It is not surprising that with candles and wax becoming increasingly more important attention was paid as to how to stabilize the said materials. At the National Candle Association Meeting in Houston, 1994, R. van der Vennet presented a paper on &ldquo;Antioxidants in Wax-Replacement of BHT&rdquo; touting the use of Vitamin E (tocopherol) as an antioxidant to prevent the yellowing of wax when oxidized. WO 94/13736 describes the same invention. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> EP 359,488 A3 and EP 133,964 B1 describe stabilized waxes used in cosmetics where the waxes are the same or similar to those used in candles. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> EP 5,922 A1 describes lip cosmetics where the waxes are useful in lipsticks and are related to those useful in candles. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> U.S. Pat. No. 5,879,694 describes in detail transparent gel candles both in composition and structure. The use of BHT as an antioxidant is mentioned. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> At the National Candle Association Technical Meeting on Apr. 16, 1998, F. A. Ballentine et al., presented a paper entitled &ldquo;Inhibiting Color Fading of Dyed Candles with CYASORB&reg; Light Absorbers&rdquo; in which the general theories of thermal oxidation and photodegradation are discussed along with data on the effect of light absorbers on color stability of dyed candle waxes. The light absorbers compared are 4-octyloxy-2-hydroxybenzophenone UV-531; 4-methoxy-2-hydroxybenzophenone UV-9; 2-(2-hydroxy-5-methylphenyl)-2H-benzotriazole UV-5365; 2-(2-hydroxy-5-tert-octylphenyl-2H-benzotriazole UV-5411 and 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole UV-2337). </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> U.S. Pat. No. 5,964,905 teaches dyed and scented candle gels containing triblock copolymers and a hydrocarbon oil of high flash point. This reference teaches that a light (UV) absorber may be used to improve the shelf stability of the candle color when exposed to visible or ultraviolet light. Two preferred absorbers are ethylhexyl p-methoxycinnamate (PARSOL&reg; MCX, Roche) and 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole (CYASORB&reg; 5411, Cytec). </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> WO 00/22037 teaches the stabilization of solid, shaped and colored wax articles, including candles, using a malonate UV absorber which may optionally contain a hindered amine moiety as part of the malonate compound structure. The wax articles are dyed with a variety of oil soluble dyes and pigments. The samples protected by dimethyl p-methoxy-benzylidinemalonate exhibited better resistance to discoloration that did samples stabilized with selected benzotriazole or benzophenone UV absorbers. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Japanese Hei 3-278554 teaches that wax crayons (drawing materials) colored by organic pigments can be stabilized by a hindered amine and/or benzotriazole. </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> In respect to wax stabilization, the use of selected hindered amines and/or benzotriazole UV absorbers is also known in the prior art as seen in U.S. Pat. Nos. 3,530,084; 4,379,721; 4,616,051 and 5,964,905 and in copending applications Ser. Nos. 09/495,495, 09/495,496 and 09/741,583. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> British 2,333,774 A and WO 00/31069 describe a number of 2-oxopiperazinyl derivatives useful for the stabilization of organic materials especially polymers and photographic materials. </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> U.S. Pat. Nos. 4,167,512 and 4,190,571 describe some 2-keto-1,4-diaza-cycloalkanes including piperazinones as light stabilizers. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> U.S. Pat. Nos. 4,547,538; 4,480,092; 5,026,848 and 5,071,981 teach various oxo-piperazinyl-triazines including oligomeric structures as light stabilizers. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> U.S. Pat. No. 4,240,961 describes the preparation of piperazinones. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> U.S. Pat. No. 6,117,995 depicts the preparation of sterically hindered amine ethers where the cyclic ring is inter alia a piperazinone. These compounds are useful as stabilizers. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> U.S. Pat. Nos. 4,033,928; 4,110,304 and 4,123,418 teach inter alia that selected piperazinones are useful in protecting epoxy resins and styrene polymers from degradation. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> None of these references teach the superior performance provided when the piperazinone compounds are used in conjunction with a UV absorber and/or antioxidant to stabilize candle wax. </paragraph>
</section>
<section>
<heading lvl="1">OBJECTS OF THE INVENTION </heading>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> The object of the invention is to provide for a white and unscented; white and scented; dyed and unscented; dyed and scented; dipped and unscented; or dipped and scented candle wax stabilized by a combination of a piperazinone compound with a UV absorber and/or antioxidant. </paragraph>
</section>
<section>
<heading lvl="1">DETAILED DISCLOSURE </heading>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> The instant invention pertains to a composition which comprises </paragraph>
<paragraph id="P-0022" lvl="2"><number>&lsqb;0022&rsqb;</number> (a) candle wax which is white and unscented; white and scented; dyed and unscented; dyed and scented; dipped and unscented; or dipped and scented, and </paragraph>
<paragraph id="P-0023" lvl="2"><number>&lsqb;0023&rsqb;</number> (b) an effective stabilizing amount of a combination of </paragraph>
<paragraph id="P-0024" lvl="3"><number>&lsqb;0024&rsqb;</number> (i) a piperazinone compound containing a moiety of formula (I) and  
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="72.009" wi="198.02475" file="US20030000130A1-20030102-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20030000130A1-20030102-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20030000130A1-20030102-C00001.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0025" lvl="3"><number>&lsqb;0025&rsqb;</number> (ii) a UV absorber or an antioxidant, or a UV absorber and an antioxidant </paragraph>
<paragraph id="P-0026" lvl="7"><number>&lsqb;0026&rsqb;</number> wherein the ratio by weight of (i) to (ii) is from 10:1 to 1:10, and </paragraph>
<paragraph id="P-0027" lvl="7"><number>&lsqb;0027&rsqb;</number> with the proviso that, when the UV absorber is a benzotriazole, said benzotriazole has only a hydrogen atom at the 5-position of the benzo ring. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> In another embodiment of the instant invention, the piperazinone compound of component (b)(i) is a compound of formula (II) or (III)  
<chemistry-cwu id="CHEM-US-00002">
<number>2</number>
<image id="EMI-C00002" he="263.05965" wi="215.0631" file="US20030000130A1-20030102-C00002.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00002" file="US20030000130A1-20030102-C00002.CDX"/>
<chemistry-mol-file id="CHEMMOL-00002" file="US20030000130A1-20030102-C00002.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0029" lvl="7"><number>&lsqb;0029&rsqb;</number> wherein </paragraph>
<paragraph id="P-0030" lvl="2"><number>&lsqb;0030&rsqb;</number> n is 1 or 2, </paragraph>
<paragraph id="P-0031" lvl="2"><number>&lsqb;0031&rsqb;</number> p is 1 to 12 </paragraph>
<paragraph id="P-0032" lvl="2"><number>&lsqb;0032&rsqb;</number> when n is 1, </paragraph>
<paragraph id="P-0033" lvl="2"><number>&lsqb;0033&rsqb;</number> G is alkyl of 1 to 18 carbon atoms, alkyl of 2 to 18 carbon atoms substituted by NH<highlight><subscript>2</subscript></highlight>, by OH, by halogen, by &mdash;OR<highlight><subscript>6</subscript></highlight>, by 4-hydroxy-3,5-di-tert-butylphenyl or by 4-hydroxy-3,5-dimethyl-phenyl, or by a mixture of these groups; or G is alkyl of 2 to 18 carbon atoms interrupted by &mdash;O&mdash;, by &mdash;CO&mdash;, by &mdash;NH&mdash; or by &mdash;NR<highlight><subscript>6</subscript></highlight>&mdash; or by a mixture of said groups; or G is alkyl of 1 to 18 carbon atoms substituted by &mdash;COOR<highlight><subscript>7 </subscript></highlight>or by phenyl; </paragraph>
<paragraph id="P-0034" lvl="2"><number>&lsqb;0034&rsqb;</number> when n is 2, </paragraph>
<paragraph id="P-0035" lvl="2"><number>&lsqb;0035&rsqb;</number> G is alkylene of 2 to 10 carbon atoms, alkenylene of 4 to 12 carbon atoms, alkylene of 3 to 15 carbon atoms substituted by one to four OH or said alkylene interrupted by one to four oxygen atoms; or G is phenylene, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4</subscript></highlight>alkylphenylene, &mdash;CO&mdash;(CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>p</subscript></highlight>&mdash;CO&mdash;, &mdash;COO&mdash;, &mdash;CONH&mdash;,  
<chemistry-cwu id="CHEM-US-00003">
<number>3</number>
<image id="EMI-C00003" he="69.37245" wi="190.82385" file="US20030000130A1-20030102-C00003.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00003" file="US20030000130A1-20030102-C00003.CDX"/>
<chemistry-mol-file id="CHEMMOL-00003" file="US20030000130A1-20030102-C00003.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0036" lvl="7"><number>&lsqb;0036&rsqb;</number> &mdash;NH&mdash; or &mdash;NR<highlight><subscript>6</subscript></highlight>&mdash;; </paragraph>
<paragraph id="P-0037" lvl="2"><number>&lsqb;0037&rsqb;</number> R<highlight><subscript>1</subscript></highlight>, R<highlight><subscript>2</subscript></highlight>, R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>are independently alkyl of 1 to 12 of carbon atoms, said alkyl substituted by one or two hydroxyl groups; or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together or R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>together or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together and R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>together are tetramethylene, pentamethylene or pentamethylene substituted by methyl; </paragraph>
<paragraph id="P-0038" lvl="2"><number>&lsqb;0038&rsqb;</number> R<highlight><subscript>1</subscript></highlight>&prime;, R<highlight><subscript>2</subscript></highlight>&prime;, R<highlight><subscript>3</subscript></highlight>&prime; and R<highlight><subscript>4</subscript></highlight>&prime; and R<highlight><subscript>1</subscript></highlight>&Prime;, R<highlight><subscript>2</subscript></highlight>&Prime;, R<highlight><subscript>3</subscript></highlight>&Prime; and R<highlight><subscript>4</subscript></highlight>&Prime; are defined as for R<highlight><subscript>1</subscript></highlight>, R<highlight><subscript>2</subscript></highlight>, R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4</subscript></highlight>; </paragraph>
<paragraph id="P-0039" lvl="2"><number>&lsqb;0039&rsqb;</number> R<highlight><subscript>5 </subscript></highlight>is hydrogen, oxyl, hydroxyl, cyanoethyl, phenylalkyl of 7 to 15 carbon atoms, said phenylalkyl substituted on the phenyl ring by one to three radicals selected from alkyl of 1 to 4 carbon atoms and alkoxy of 1 to 4 carbon atoms, phenylalkoxy of 7 to 15 carbon atoms, said phenylalkoxy substituted on the phenyl ring by one to three radicals selected from alkyl of 1 to 4 carbon atoms and alkoxy of 1 to 4 carbon atoms, cycloalkoxy of 5 to 12 carbon atoms, alkenyl of 3 to 8 carbon atoms, alkynyl of 3 to 8 carbon atoms, alkoxy of 1 to 24 carbon atoms, alkyl of 1 to 24 carbon atoms, said alkyl substituted by one or two hydroxyl groups, said alkyl substituted by alkylcarbonyloxy of 2 to 18 carbon atoms, or said alkyl interrupted by one to twenty oxygen atoms and substituted by one hydroxyl, by alkylcarbonyloxy of 2 to 18 carbon atoms or by 4-hydroxy-3,5-di-tert-butylbenzoyloxy; or R<highlight><subscript>5 </subscript></highlight>is alkanoyl of 1 to 8 carbon atoms, alkenoyl of 3 to 5 carbon atoms, alkanoyloxy of 1 to 18 carbon atoms, glycidyl, or a group &mdash;CH<highlight><subscript>2</subscript></highlight>CH(OH)&mdash;E where E is hydrogen, methyl or phenyl; </paragraph>
<paragraph id="P-0040" lvl="2"><number>&lsqb;0040&rsqb;</number> R<highlight><subscript>5</subscript></highlight>&prime; and R<highlight><subscript>5</subscript></highlight>&Prime; are defined as for R<highlight><subscript>5</subscript></highlight>; </paragraph>
<paragraph id="P-0041" lvl="2"><number>&lsqb;0041&rsqb;</number> X is &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NR<highlight><subscript>6</subscript></highlight>&mdash;; </paragraph>
<paragraph id="P-0042" lvl="2"><number>&lsqb;0042&rsqb;</number> Z is &mdash;NH<highlight><subscript>2</subscript></highlight>, &mdash;NHR<highlight><subscript>6</subscript></highlight>, &mdash;N(R<highlight><subscript>6</subscript></highlight>)<highlight><subscript>2 </subscript></highlight>or alkoxy of 1 to 18 carbon atoms; </paragraph>
<paragraph id="P-0043" lvl="2"><number>&lsqb;0043&rsqb;</number> R<highlight><subscript>6 </subscript></highlight>is alkyl of 1 to 8 carbon atoms, alkanoyl of 1 to 8 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms which is unsubstituted or substituted on the phenyl ring by alkyl of 1 to 4 carbon atoms, by alkoxy or 1 to 4 carbon atoms or by a mixture of said groups; or R<highlight><subscript>6 </subscript></highlight>is alkyl of 1 to 8 carbon atoms or alkanoyl of 1 to 8 carbon atoms substituted by &mdash;OH, by alkoxy of 1 to 12 carbon atoms, by benzophenonyl or benzophenonyloxy where one or both phenyl rings of the benzophenone moiety are unsubstituted or substituted by OH, by halogen, by alkyl of 1 to 4 carbon atoms, by alkoxy of 1 to 4 carbon atoms or by a mixture of such groups; </paragraph>
<paragraph id="P-0044" lvl="2"><number>&lsqb;0044&rsqb;</number> R<highlight><subscript>6</subscript></highlight>&prime; and R<highlight><subscript>6</subscript></highlight>&Prime; are defined as for R<highlight><subscript>6</subscript></highlight>; and </paragraph>
<paragraph id="P-0045" lvl="2"><number>&lsqb;0045&rsqb;</number> R<highlight><subscript>7 </subscript></highlight>is hydrogen, alkyl of 1 to 18 carbon atoms, alkyl of 2 to 18 carbon atoms which is substituted by &mdash;NH<highlight><subscript>2</subscript></highlight>, by &mdash;NHR<highlight><subscript>6</subscript></highlight>, by &mdash;N(R<highlight><subscript>6</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, by nitro, by hydroxy, by alkoxy of 1 to 18 carbon atoms or by a mixture of said groups; or R<highlight><subscript>7 </subscript></highlight>is alkenyl of 3 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, or said cycloalkyl which is substituted by alkyl of 1 to 4 carbon atoms or is interrupted by &mdash;O&mdash;, or R<highlight><subscript>7 </subscript></highlight>is phenyl or phenylalkyl of 7 to 15 carbon atoms. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> In another embodiment of the invention R<highlight><subscript>1</subscript></highlight>, R<highlight><subscript>2</subscript></highlight>, R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>are each methyl, or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together and R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>together are pentamethylene. </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> In another embodiment of the invention, R<highlight><subscript>5 </subscript></highlight>is hydrogen or methyl. </paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> In still another embodiment of the invention, R<highlight><subscript>7 </subscript></highlight>is n-butyl or cyclohexyl. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> Specific piperazinone compounds of formula (II) or (III) which are useful in the instant invention include </paragraph>
<paragraph id="P-0050" lvl="1"><number>&lsqb;0050&rsqb;</number> (a) 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine; </paragraph>
<paragraph id="P-0051" lvl="1"><number>&lsqb;0051&rsqb;</number> (b) 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(1,2,2,6,6-pentamethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine; </paragraph>
<paragraph id="P-0052" lvl="1"><number>&lsqb;0052&rsqb;</number> (c) 1,2-ethane-bis(3,3,5,5-tetramethylpiperazin-2-on-1-yl); </paragraph>
<paragraph id="P-0053" lvl="1"><number>&lsqb;0053&rsqb;</number> (d) 7-methyl-7, 15-diazadispiro&lsqb;5.1.5.3&rsqb;hexadecane-14-one; </paragraph>
<paragraph id="P-0054" lvl="1"><number>&lsqb;0054&rsqb;</number> (e) 1,3,3,5,5-pentamethyl-4-(2-hydroxyethyl)-2-ketopiperazine; </paragraph>
<paragraph id="P-0055" lvl="1"><number>&lsqb;0055&rsqb;</number> (f) 3,3,5,5-tetramethyl-4-octyloxy-1-octyl-2-ketopiperazine; </paragraph>
<paragraph id="P-0056" lvl="1"><number>&lsqb;0056&rsqb;</number> (g) 1,3,3,5,5-pentamethyl-4-oxyl-2-ketopiperazine; </paragraph>
<paragraph id="P-0057" lvl="1"><number>&lsqb;0057&rsqb;</number> (h) 3,3,4,5,5-pentamethyl-1-(2-hydroxyethyl)piperazin-2-one; </paragraph>
<paragraph id="P-0058" lvl="1"><number>&lsqb;0058&rsqb;</number> (i) 3,3,5,5-tetramethyl-4-cyclohexyloxy-1-&lsqb;2-(dodecanoyloxy)ethyl&rsqb;piperazin-2-one; </paragraph>
<paragraph id="P-0059" lvl="1"><number>&lsqb;0059&rsqb;</number> (j) bis&lsqb;2-(4-cyclohexyloxy-3,3,5,5-tetramethyl-2-ketopiperazin-1-yl)ethyl&rsqb; sebacate; and </paragraph>
<paragraph id="P-0060" lvl="1"><number>&lsqb;0060&rsqb;</number> (k) 4-octyloxy-3,3,5,5-tetramethyl-1-octadecylpiperazin-2-one. </paragraph>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> Another embodiment of the instant invention is where the piperazinone compound of component (b)(i) is </paragraph>
<paragraph id="P-0062" lvl="1"><number>&lsqb;0062&rsqb;</number> (a) 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine; </paragraph>
<paragraph id="P-0063" lvl="1"><number>&lsqb;0063&rsqb;</number> (b) 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(1,2,2,6,6-pentamethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine; or </paragraph>
<paragraph id="P-0064" lvl="1"><number>&lsqb;0064&rsqb;</number> (c) 1,2-ethane-bis(3,3,5,5-tetramethylpiperazin-2-on-1-yl). </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> In another embodiment of the invention, the ratio by weight of (i) to (ii) is from 4:1 to 1:4. </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> Another embodiment of the invention is where the ratio by weight of (i) to (ii) is from 2:1 to 1:2. </paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> In still another embodiment of the invention, the effective amount of the UV absorber plus the piperazinone compound in the candle wax is 0.01 to 10% by weight based on the wax. </paragraph>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> In another embodiment of the invention the effective amount of the UV absorber plus piperazinone in the candle wax is 0.1 to 2% by weight based on the wax. </paragraph>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> In still another embodiments of the invention the effective amount of the UV absorber plus piperazinone in the candle wax is 0.1 to 0.5% by weight based on the wax. </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> The UV absorber of component (ii) is a benzotriazole, a benzophenone, an &agr;-cyanoacrylate, an oxanilide, an s-triazine, a cinnamate, a malonate, a benzoate or a salicylate, or a mixture thereof, with the proviso that, when the UV absorber is a benzotriazole, said benzotriazole has only a hydrogen atom at the 5-position of the benzo ring. </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> In another embodiment of the invention, the UV absorber is a benzotriazole, a benzophenone or an s-triazine. </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> Examples of the UV absorbers useful in the instant invention are </paragraph>
<paragraph id="P-0073" lvl="1"><number>&lsqb;0073&rsqb;</number> (a) 4-octyloxy-2-hydroxybenzophenone; </paragraph>
<paragraph id="P-0074" lvl="1"><number>&lsqb;0074&rsqb;</number> (b) 4-methoxy-2-hydroxybenzophenone; </paragraph>
<paragraph id="P-0075" lvl="1"><number>&lsqb;0075&rsqb;</number> (c) 2-(2-hydroxy-5-methylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0076" lvl="1"><number>&lsqb;0076&rsqb;</number> (d) 2-(2-hydroxy-5sert-octylphenyl-2H-benzotriazole; </paragraph>
<paragraph id="P-0077" lvl="1"><number>&lsqb;0077&rsqb;</number> (e) 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0078" lvl="1"><number>&lsqb;0078&rsqb;</number> (f) octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate; </paragraph>
<paragraph id="P-0079" lvl="1"><number>&lsqb;0079&rsqb;</number> (g) 2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0080" lvl="1"><number>&lsqb;0080&rsqb;</number> (h) 2-(2-hydroxy-5-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0081" lvl="1"><number>&lsqb;0081&rsqb;</number> (i) 2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0082" lvl="1"><number>&lsqb;0082&rsqb;</number> (j) 2-(2-hydroxy-3-tert-butyl-5-methylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0083" lvl="1"><number>&lsqb;0083&rsqb;</number> (k) 2-(2-hydroxy-3-sec-butyl-5-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0084" lvl="1"><number>&lsqb;0084&rsqb;</number> (l) 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0085" lvl="1"><number>&lsqb;0085&rsqb;</number> (m) 2-(2-hydroxy-3-dodecyl-5-methylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0086" lvl="1"><number>&lsqb;0086&rsqb;</number> (n) 2-&lsqb;2-hydroxy-3,5-di(&agr;,&agr;-dimethylbenzyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0087" lvl="1"><number>&lsqb;0087&rsqb;</number> (o) 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0088" lvl="1"><number>&lsqb;0088&rsqb;</number> (p) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)ethyl&rsqb;-phenyl&rcub;-2H-benzotriazole; and </paragraph>
<paragraph id="P-0089" lvl="1"><number>&lsqb;0089&rsqb;</number> (q) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H- benzotriazole; </paragraph>
<paragraph id="P-0090" lvl="1"><number>&lsqb;0090&rsqb;</number> (r) 2-ethylhexyl p-methoxycinnamate; </paragraph>
<paragraph id="P-0091" lvl="1"><number>&lsqb;0091&rsqb;</number> (s) 4-methoxy-2,2&prime;-dihydroxybenzophenone; </paragraph>
<paragraph id="P-0092" lvl="1"><number>&lsqb;0092&rsqb;</number> (t) 4,4&prime;dimethoxy-2,2&prime;-dihydroxybenzophenone; </paragraph>
<paragraph id="P-0093" lvl="1"><number>&lsqb;0093&rsqb;</number> (u) 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine; </paragraph>
<paragraph id="P-0094" lvl="1"><number>&lsqb;0094&rsqb;</number> (v) 2,4-diphenyl-6-(2-hydroxy-4-hexyloxyphenyl)-s-triazine; </paragraph>
<paragraph id="P-0095" lvl="1"><number>&lsqb;0095&rsqb;</number> (w) 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)-phenyl&rsqb;-s-triazine; </paragraph>
<paragraph id="P-0096" lvl="1"><number>&lsqb;0096&rsqb;</number> (x) 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)-5-&agr;-cumylphenyl&rsqb;-s-triazine; </paragraph>
<paragraph id="P-0097" lvl="1"><number>&lsqb;0097&rsqb;</number> (y) reaction product of 2,4,6-tris(2,4-dihydroxyphenyl)-s-triazine with octyl &agr;-haloacetate; or </paragraph>
<paragraph id="P-0098" lvl="1"><number>&lsqb;0098&rsqb;</number> (z) the mixture of 3,3;3,5;5,5-methylene-bis&lsqb;2,4-bis(2,4-dimethylphenyl)&rsqb;-6-&lsqb;2-hydroxy-4-(3-butyloxy-2-hydroxypropoxyphenyl)&rsqb;-s-triazine. </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> Still other examples of UV absorbers useful in the instant invention are </paragraph>
<paragraph id="P-0100" lvl="1"><number>&lsqb;0100&rsqb;</number> (a) 4-octyloxy-2-hydroxybenzophenone; </paragraph>
<paragraph id="P-0101" lvl="1"><number>&lsqb;0101&rsqb;</number> (b) 4-methoxy-2-hydroxybenzophenone; </paragraph>
<paragraph id="P-0102" lvl="1"><number>&lsqb;0102&rsqb;</number> (d) 2-(2-hydroxy-5-tert-octylphenyl-2H-benzotriazole; </paragraph>
<paragraph id="P-0103" lvl="1"><number>&lsqb;0103&rsqb;</number> (o) 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0104" lvl="1"><number>&lsqb;0104&rsqb;</number> (p) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0105" lvl="1"><number>&lsqb;0105&rsqb;</number> (q) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0106" lvl="1"><number>&lsqb;0106&rsqb;</number> (y) reaction product of 2,4,6-tris(2,4-dihydroxyphenyl)-s-triazine with octyl &agr;-haloacetate; or </paragraph>
<paragraph id="P-0107" lvl="1"><number>&lsqb;0107&rsqb;</number> (z) the mixture of 3,3;3,5;5,5-methylene-bis&lsqb;2,4-bis(2,4-dimethylphenyl)&rsqb;-6-&lsqb;2-hydroxy-4-(3-butyloxy-2-hydroxypropoxyphenyl)&rsqb;-s-triazine. </paragraph>
<paragraph id="P-0108" lvl="0"><number>&lsqb;0108&rsqb;</number> Another embodiment of the instant invention involves a composition wherein the antioxidant is a phenolic antioxidant, phosphite, nitrone, amine oxide or hydroxylamine, or mixture thereof. </paragraph>
<paragraph id="P-0109" lvl="0"><number>&lsqb;0109&rsqb;</number> Examples of the above embodiment are those wherein the effective amount of UV absorber in combination with the piperazinone compound and an antioxidant is 0.01 to 10% by weight based on the wax. </paragraph>
<paragraph id="P-0110" lvl="0"><number>&lsqb;0110&rsqb;</number> Another embodiment is where the effective amount of UV absorber in combination with the piperazinone and an antioxidant is 0.1 to 2% by weight based on the wax. </paragraph>
<paragraph id="P-0111" lvl="0"><number>&lsqb;0111&rsqb;</number> Still another embodiment is where the effective amount of UV absorber in combination with the piperazinone and an antioxidant is 0.1 to 0.5% by weight based on the wax. </paragraph>
<paragraph id="P-0112" lvl="0"><number>&lsqb;0112&rsqb;</number> Examples of the antioxidants useful in this invention are </paragraph>
<paragraph id="P-0113" lvl="1"><number>&lsqb;0113&rsqb;</number> n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, </paragraph>
<paragraph id="P-0114" lvl="1"><number>&lsqb;0114&rsqb;</number> neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinammate), </paragraph>
<paragraph id="P-0115" lvl="1"><number>&lsqb;0115&rsqb;</number> di-n-octadecyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate, </paragraph>
<paragraph id="P-0116" lvl="1"><number>&lsqb;0116&rsqb;</number> 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, </paragraph>
<paragraph id="P-0117" lvl="1"><number>&lsqb;0117&rsqb;</number> thiodiethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </paragraph>
<paragraph id="P-0118" lvl="1"><number>&lsqb;0118&rsqb;</number> 1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, </paragraph>
<paragraph id="P-0119" lvl="1"><number>&lsqb;0119&rsqb;</number> 3,6-dioxaoctamethylene bis(3-methyl-5-tert-butyl-4-hydroxyhydrocinnamate), </paragraph>
<paragraph id="P-0120" lvl="1"><number>&lsqb;0120&rsqb;</number> 2,6-di-tert-butyl-p-cresol, </paragraph>
<paragraph id="P-0121" lvl="1"><number>&lsqb;0121&rsqb;</number> 2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol), </paragraph>
<paragraph id="P-0122" lvl="1"><number>&lsqb;0122&rsqb;</number> 1,3,5-tris(2,6-dimethyl-4-tert-butyl-3-hydroxybenzyl) isocyanurate, </paragraph>
<paragraph id="P-0123" lvl="1"><number>&lsqb;0123&rsqb;</number> 1,1,3,-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane, </paragraph>
<paragraph id="P-0124" lvl="1"><number>&lsqb;0124&rsqb;</number> 1,3,5-tris&lsqb;2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)ethyl&rsqb; isocyanurate, </paragraph>
<paragraph id="P-0125" lvl="1"><number>&lsqb;0125&rsqb;</number> 3,5-di-(3,5-di-ert-butyl-4-hydroxybenzyl)mesitol, </paragraph>
<paragraph id="P-0126" lvl="1"><number>&lsqb;0126&rsqb;</number> hexamethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </paragraph>
<paragraph id="P-0127" lvl="1"><number>&lsqb;0127&rsqb;</number> 1-(3,5-di-tert-butyl-4-hydroxyanilino)-3,5-di(octylthio)-s-triazine, </paragraph>
<paragraph id="P-0128" lvl="1"><number>&lsqb;0128&rsqb;</number> N,N&prime;-hexamethylene-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamamide), </paragraph>
<paragraph id="P-0129" lvl="1"><number>&lsqb;0129&rsqb;</number> calcium bis(ethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate), </paragraph>
<paragraph id="P-0130" lvl="1"><number>&lsqb;0130&rsqb;</number> ethylene bis&lsqb;3,3-di(3-tert-butyl-4-hydroxyphenyl)butyrate&rsqb;, </paragraph>
<paragraph id="P-0131" lvl="1"><number>&lsqb;0131&rsqb;</number> octyl 3,5-di-tert-butyl-4-hydroxybenzylmercaptoacetate, </paragraph>
<paragraph id="P-0132" lvl="1"><number>&lsqb;0132&rsqb;</number> bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazide, N,N&prime;-bis&lsqb;2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)-ethyl&rsqb;oxamide, </paragraph>
<paragraph id="P-0133" lvl="1"><number>&lsqb;0133&rsqb;</number> N,N-di-(C<highlight><subscript>12</subscript></highlight>-C<highlight><subscript>24</subscript></highlight>alkyl)-N-methyl-amine oxide, or </paragraph>
<paragraph id="P-0134" lvl="1"><number>&lsqb;0134&rsqb;</number> N,N-dialkylhydroxylamine prepared from di(hydrogenated tallow)amine by direct oxidation. </paragraph>
<paragraph id="P-0135" lvl="0"><number>&lsqb;0135&rsqb;</number> Still other embodiments of antioxidants useful in the instant invention are </paragraph>
<paragraph id="P-0136" lvl="1"><number>&lsqb;0136&rsqb;</number> neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </paragraph>
<paragraph id="P-0137" lvl="1"><number>&lsqb;0137&rsqb;</number> n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, </paragraph>
<paragraph id="P-0138" lvl="1"><number>&lsqb;0138&rsqb;</number> 1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, </paragraph>
<paragraph id="P-0139" lvl="1"><number>&lsqb;0139&rsqb;</number> 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, </paragraph>
<paragraph id="P-0140" lvl="1"><number>&lsqb;0140&rsqb;</number> 2,6-di-tert-butyl-p-cresol, or </paragraph>
<paragraph id="P-0141" lvl="1"><number>&lsqb;0141&rsqb;</number> 2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol). </paragraph>
<paragraph id="P-0142" lvl="0"><number>&lsqb;0142&rsqb;</number> It should be noted that candles contain a host of various components. The base materials may be made up of the following: </paragraph>
<paragraph id="P-0143" lvl="1"><number>&lsqb;0143&rsqb;</number> paraffin wax, </paragraph>
<paragraph id="P-0144" lvl="1"><number>&lsqb;0144&rsqb;</number> natural oils, </paragraph>
<paragraph id="P-0145" lvl="1"><number>&lsqb;0145&rsqb;</number> polyamide plus fatty acid/ester, </paragraph>
<paragraph id="P-0146" lvl="1"><number>&lsqb;0146&rsqb;</number> fatty acids such as stearin, </paragraph>
<paragraph id="P-0147" lvl="1"><number>&lsqb;0147&rsqb;</number> opacifiers, </paragraph>
<paragraph id="P-0148" lvl="1"><number>&lsqb;0148&rsqb;</number> beeswax, </paragraph>
<paragraph id="P-0149" lvl="1"><number>&lsqb;0149&rsqb;</number> glycerides plus oxidized wax, </paragraph>
<paragraph id="P-0150" lvl="1"><number>&lsqb;0150&rsqb;</number> alcohols, and </paragraph>
<paragraph id="P-0151" lvl="1"><number>&lsqb;0151&rsqb;</number> ethylene oligomers. </paragraph>
<paragraph id="P-0152" lvl="0"><number>&lsqb;0152&rsqb;</number> Candles also contain a number of additives such as the following: </paragraph>
<paragraph id="P-0153" lvl="1"><number>&lsqb;0153&rsqb;</number> mold release agents, </paragraph>
<paragraph id="P-0154" lvl="1"><number>&lsqb;0154&rsqb;</number> fragrances, </paragraph>
<paragraph id="P-0155" lvl="1"><number>&lsqb;0155&rsqb;</number> insect repellants or insecticides, </paragraph>
<paragraph id="P-0156" lvl="1"><number>&lsqb;0156&rsqb;</number> hardeners, </paragraph>
<paragraph id="P-0157" lvl="1"><number>&lsqb;0157&rsqb;</number> crystal modifiers, </paragraph>
<paragraph id="P-0158" lvl="1"><number>&lsqb;0158&rsqb;</number> clarifiers, </paragraph>
<paragraph id="P-0159" lvl="1"><number>&lsqb;0159&rsqb;</number> guttering reducers, </paragraph>
<paragraph id="P-0160" lvl="1"><number>&lsqb;0160&rsqb;</number> colorants, </paragraph>
<paragraph id="P-0161" lvl="1"><number>&lsqb;0161&rsqb;</number> f.p. control agents, </paragraph>
<paragraph id="P-0162" lvl="1"><number>&lsqb;0162&rsqb;</number> stretchability improvers, </paragraph>
<paragraph id="P-0163" lvl="1"><number>&lsqb;0163&rsqb;</number> gelling agents, </paragraph>
<paragraph id="P-0164" lvl="1"><number>&lsqb;0164&rsqb;</number> extrusion aids, and </paragraph>
<paragraph id="P-0165" lvl="1"><number>&lsqb;0165&rsqb;</number> vortex reducers. </paragraph>
<paragraph id="P-0166" lvl="0"><number>&lsqb;0166&rsqb;</number> Each of the various components are meant to control or modify the properties of the candle to insure proper burning, reduce channelling, aid in uniform melting, and the like. The colorants and fragrances obviously are there to provide the proper color, scent or other aesthetic appeal. </paragraph>
<paragraph id="P-0167" lvl="0"><number>&lsqb;0167&rsqb;</number> Of increasing importance are the transparent gel candles which look like clear glass, but which burn like a classical candle. As is discussed in detail in U.S. Pat. No. 5,879,694, the relevant parts of which are incorporated herein by reference, these gel candles usually contain a copolymer selected from the group consisting of a triblock, radial block, diblock or multiblock copolymer classically made up of at least two thermodynamically incompatible segments containing both hard and soft segments. Typical of such block copolymers is KRATON&reg; (Shell Chemical Co.) which consists of block segments of styrene monomer units and rubber monomer or comonomer units. The most common structure found in KRATON&reg; D series is a linear ABA block with styrene-butadiene-styrene (SBS) or styrene-isoprene-styrene (SIS). </paragraph>
<paragraph id="P-0168" lvl="0"><number>&lsqb;0168&rsqb;</number> The following examples are meant for illustrative purposes only and are not to be construed to limit the instant invention in any manner whatsoever. </paragraph>
<paragraph id="P-0169" lvl="7"><number>&lsqb;0169&rsqb;</number> Raw Materials </paragraph>
<paragraph id="P-0170" lvl="0"><number>&lsqb;0170&rsqb;</number> Wax samples are supplied by the Candle-Lite Corporation. These samples contain dyes and fragrances. </paragraph>
<paragraph id="P-0171" lvl="0"><number>&lsqb;0171&rsqb;</number> The UV absorbers and hindered amine stabilizers are obtained from the Ciba Speciality Chemicals Corporation. </paragraph>
<paragraph id="P-0172" lvl="7"><number>&lsqb;0172&rsqb;</number> Sample Preparation </paragraph>
<paragraph id="P-0173" lvl="0"><number>&lsqb;0173&rsqb;</number> The wax samples obtained from the Candle-Lite Corporation already contain a dye and a fragrance (scent). In these cases, the wax is melted and the appropriate stabilizer(s) is (are) added and dissolved in the molten wax. The stabilized wax is then poured into five (5) 44 mm diameter aluminum pans giving five (5) wax disks. </paragraph>
<paragraph id="P-0174" lvl="7"><number>&lsqb;0174&rsqb;</number> Sample Exposure </paragraph>
<paragraph id="P-0175" lvl="0"><number>&lsqb;0175&rsqb;</number> Triplicate samples of each disk are exposed under a bank of six (6) cool-white fluorescent lamps (40 watts) or under a bank of six (6) UV lamps having a wavelength of 368 nm with the test samples being twelve (12) inches (30.48 cm) below the lamps. </paragraph>
<paragraph id="P-0176" lvl="0"><number>&lsqb;0176&rsqb;</number> Dye color fade (or color change) is measured by a Macbeth ColorEye Spectrophotometer with a 6 inch integrating sphere. The conditions are: 10 degree observer; D65 illuminant and 8 degree viewing angle. </paragraph>
<paragraph id="P-0177" lvl="0"><number>&lsqb;0177&rsqb;</number> Initial color measurements are taken using the above parameters. The L, a and b values are calculated using the CIE system from the reflectance values. YI is calculated from the L, a and b values. Subsequent measurements are taken at specified intervals. Delta L, a, b and YI values are simply the difference between the initial values and the values at each interval. Delta(&Dgr;) E is calculated as follows:</paragraph>
<paragraph lvl="0"><in-line-formula>&lsqb;(Delta <highlight><italic>L</italic></highlight>)<highlight><superscript>2</superscript></highlight>&plus;(Delta <highlight><italic>a</italic></highlight>)<highlight><superscript>2</superscript></highlight>&plus;(Delta <highlight><italic>b</italic></highlight>)<highlight><superscript>2</superscript></highlight>&rsqb;<highlight><superscript>&frac12;</superscript></highlight>&equals;Delta <highlight><italic>E.</italic></highlight></in-line-formula></paragraph>
</section>
</summary-of-invention>
<detailed-description>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
</section>
<section>
<heading lvl="1">1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethyl-piperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine </heading>
<paragraph id="P-0178" lvl="0"><number>&lsqb;0178&rsqb;</number> This compound is a commercial stabilizer GOODRITE&reg; 3150, obtained from the Goodrite Corporation and is made by the general procedures given in U.S. Pat. No. 4,547,538. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
</section>
<section>
<heading lvl="1">1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(1,2,2,6,6-pentamethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine </heading>
<paragraph id="P-0179" lvl="0"><number>&lsqb;0179&rsqb;</number> This compound is a commercial stabilizer GOODRITE&reg; 3159, obtained from the Goodrite Corporation and is made by the general procedures given in U.S. Pat. No. 4,547,538. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 3 </heading>
</section>
<section>
<heading lvl="1">1,2-ethane-bis(3,3,5,5-tetramethylpiperazin-2-on-1-yl) </heading>
<paragraph id="P-0180" lvl="0"><number>&lsqb;0180&rsqb;</number> This compound is a commercial stabilizer GOODRITE&reg; 3034, obtained from the Goodrite Corporation and is made by the general procedures given in U.S. Pat. No. 4,547,538. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 4 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Pink Scented Candle Wax Under Fluorescent Lamp Exposure </heading>
<paragraph id="P-0181" lvl="0"><number>&lsqb;0181&rsqb;</number> A variety of different stabilizers are evaluated in pink scented candle wax obtained from the Candle-Lite Corporation under fluorescent lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>35 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>13.66</entry>
</row>
<row>
<entry></entry>
<entry>A (0.3%)</entry>
<entry>10.04</entry>
</row>
<row>
<entry></entry>
<entry>D (0.3%)</entry>
<entry>9.37</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%) &plus;</entry>
<entry>7.12</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>A (0.15%) &plus;</entry>
<entry>3.96</entry>
</row>
<row>
<entry></entry>
<entry>D (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>G (0.15%) &plus;</entry>
<entry>2.78</entry>
</row>
<row>
<entry></entry>
<entry>F (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>H (0.15%) &plus;</entry>
<entry>2.46</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>G (0.15%) &plus;</entry>
<entry>1.80</entry>
</row>
<row>
<entry></entry>
<entry>E (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00001">*A is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00002">B is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00003">C is 4-octyloxy-2-hydroxybenzophenone, CHIMMASORB&thinsp;&reg; 81, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00004">D is bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, TINUVIN&thinsp;&reg; 292, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00005">E is 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine, UV 1164, CYTEC. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00006">F is ethyl 2-cyano-3,3-diphenylacrylate, UVINUL&thinsp;&reg; N-35, BASF. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00007">G is 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine, GOODRITE&thinsp;&reg; 3150, GOODRITE, the compound of Example 1. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00008">H is 1,2-ethane-bis(3,3,5,5-tetramethylpiperazin-2-on-1-yl), GOODRITE&thinsp;&reg; 3034, GOODRITE, the compound of Example 3. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0182" lvl="0"><number>&lsqb;0182&rsqb;</number> These data show that a piperazinone compound (Compound G or H) in combination with a UV absorber protects the pink scented candle wax from unwanted discoloration far better than conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 5 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Pink Scented Candle Wax Under UV Lamp Exposure </heading>
<paragraph id="P-0183" lvl="0"><number>&lsqb;0183&rsqb;</number> A variety of different stabilizers are evaluated in pink scented candle wax obtained from the Candle-Lite Corporation under UV lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>37 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>20.27</entry>
</row>
<row>
<entry></entry>
<entry>D (0.3%)</entry>
<entry>15.88</entry>
</row>
<row>
<entry></entry>
<entry>A (0.15%) &plus;</entry>
<entry>7.32</entry>
</row>
<row>
<entry></entry>
<entry>D (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%)</entry>
<entry>9.62</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>H (0.15%) &plus;</entry>
<entry>4.83</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>G (0.15%) &plus;</entry>
<entry>2.88</entry>
</row>
<row>
<entry></entry>
<entry>E (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00009">*A is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00010">B is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00011">C is 4-octyloxy-2-hydroxybenzophenone, CHIMMASORB&thinsp;&reg; 81, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00012">D is bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, TINUVIN&thinsp;&reg; 292, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00013">E is 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine, UV 1164, CYTEC. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00014">G is 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine, GOODRITE&thinsp;&reg; 3150, GOODRITE, the compound of Example 1. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00015">H is 1,2-ethane-bis(3,3,5,5-tetramethylpiperazin-2-on-1-yl), GOODRITE&thinsp;&reg; 3034, GOODRITE, the compound of Example 3. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0184" lvl="0"><number>&lsqb;0184&rsqb;</number> These data show that a piperazinone compound (Compound G or H) in combination with a UV absorber protects the pink scented candle wax from unwanted discoloration far better than conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 6 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Gray Scented Candle Wax Under Fluorescent Lamp Exposure </heading>
<paragraph id="P-0185" lvl="0"><number>&lsqb;0185&rsqb;</number> A variety of different stabilizers are evaluated in gray scented candle wax obtained from the Candle-Lite Corporation under fluorescent lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>34 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>16.01</entry>
</row>
<row>
<entry></entry>
<entry>A (0.3%)</entry>
<entry>11.26</entry>
</row>
<row>
<entry></entry>
<entry>I (0.3%)</entry>
<entry>11.32</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%) &plus;</entry>
<entry>8.52</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>A (0.15%) &plus;</entry>
<entry>3.16</entry>
</row>
<row>
<entry></entry>
<entry>I (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>H (0.15%) &plus;</entry>
<entry>2.76</entry>
</row>
<row>
<entry></entry>
<entry>A (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00016">*A is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00017">B is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00018">C is 4-octyloxy-2-hydroxybenzophenone, CHIMMASORB&thinsp;&reg; 81, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00019">H is 1,2-ethane-bis(3,3,5,5-tetramethylpiperazin-2-on-1-yl), GOODRITE&thinsp;&reg; 3034, GOODRITE, the compound of Example 3. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00020">I is bis(1-octyloxy-2,2,6,6-tetramethylpiperdin-4-yl) sebacate, TINUVIN&thinsp;&reg; 123, CIBA. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0186" lvl="0"><number>&lsqb;0186&rsqb;</number> These data show that a piperazinone compound (Compound H) in combination with a UV absorber protects the gray scented candle wax from unwanted discoloration far better than conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 7 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Gray Scented Candle Wax Under UV Lamp Exposure </heading>
<paragraph id="P-0187" lvl="0"><number>&lsqb;0187&rsqb;</number> A variety of different stabilizers are evaluated in gray scented candle wax obtained from the Candle-Lite Corporation under UV lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00004">
<number>4</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>26 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>29.81</entry>
</row>
<row>
<entry></entry>
<entry>I (0.3%)</entry>
<entry>25.37</entry>
</row>
<row>
<entry></entry>
<entry>A (0.3%)</entry>
<entry>9.45</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%) &plus;</entry>
<entry>10.27</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>A (0.15%) &plus;</entry>
<entry>4.81</entry>
</row>
<row>
<entry></entry>
<entry>I (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>H (0.15%) &plus;</entry>
<entry>3.71</entry>
</row>
<row>
<entry></entry>
<entry>A (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00021">*A is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00022">B is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00023">C is 4-octyloxy-2-hydroxybenzophenone, CHIMMASORB&thinsp;&reg; 81, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00024">H is 1,2-ethane-bis(3,3,5,5-tetramethylpiperazin-2-on-1-yl), GOODRITE&thinsp;&reg; 3034, GOODRITE, the compound of Example 3. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00025">I is bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, TINUVIN&thinsp;&reg; 123, CIBA. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0188" lvl="0"><number>&lsqb;0188&rsqb;</number> These data show that a piperazinone compound (Compound H) in combination with a UV absorber protects the gray scented candle wax from unwanted discoloration far better than conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 8 </heading>
</section>
<section>
<heading lvl="1">Color Fade of White Scented Candle Wax Under Fluorescent Lamp Exposure </heading>
<paragraph id="P-0189" lvl="0"><number>&lsqb;0189&rsqb;</number> A variety of different stabilizers are evaluated in white scented candle wax obtained from the Candle-Lite Corporation under fluorescent lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00005">
<number>5</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>33 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>34.68</entry>
</row>
<row>
<entry></entry>
<entry>A (0.3%)</entry>
<entry>30.74</entry>
</row>
<row>
<entry></entry>
<entry>D (0.3%)</entry>
<entry>32.86</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%) &plus;</entry>
<entry>21.24</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>A (0.15%) &plus;</entry>
<entry>30.31</entry>
</row>
<row>
<entry></entry>
<entry>D (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%) &plus;</entry>
<entry>25.09</entry>
</row>
<row>
<entry></entry>
<entry>D (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>G (0.15%) &plus;</entry>
<entry>17.23</entry>
</row>
<row>
<entry></entry>
<entry>E (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00026">*A is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00027">B is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00028">C is 4-octyloxy-2-hydroxybenzophenone, CHIMMASORB&thinsp;&reg; 81, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00029">D is bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, TINUVIN&thinsp;&reg; 292, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00030">E is 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine, UV 1164, CYTEC. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00031">G is 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine, GOODRITE&thinsp;&reg; 3150, GOODRITE, the compound of Example 1. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0190" lvl="0"><number>&lsqb;0190&rsqb;</number> These data show that a piperazinone compound (Compound G) in combination with a UV absorber protects the white scented candle wax from unwanted discoloration far better than conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 9 </heading>
<paragraph id="P-0191" lvl="0"><number>&lsqb;0191&rsqb;</number> Green scented candle wax is well stabilized by 0.2% by weight of dimethyl p-methoxy-benzylidenemalonate, SANDUVOR&reg; PR 25, in combination with 0.2% by weight of 7-methyl-7,15-diazadispiro&lsqb;5.1.5.3&rsqb;hexadecane-14-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 10 </heading>
<paragraph id="P-0192" lvl="0"><number>&lsqb;0192&rsqb;</number> Yellow scented candle wax is well stabilized by 0.1% by weight of di(1,2,2,6,6-penta-methylpiperidin-4-yl) p-methoxybenzylidenemalonate, SANDUVOR&reg; PR 31, in combination with 0.1% by weight of 1,3,3,5,5-pentamethyl-4-(2-hydroxyethyl)-2-ketopiperazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 11 </heading>
<paragraph id="P-0193" lvl="0"><number>&lsqb;0193&rsqb;</number> Red unscented candle wax is well stabilized by 0.1% by weight of dimethyl di(p-chloro-phenyl)methylenemalonate in combination with 0.1% by weight of 3,3,5,5-tetramethyl-4-octyl-oxy-1-octyl-2-ketopiperazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 12 </heading>
<paragraph id="P-0194" lvl="0"><number>&lsqb;0194&rsqb;</number> Red unscented candle wax is well stabilized by 0.2% by weight of dimethyl di(p-methoxyphenyl)methylenemalonate in combination with 0.2% by weight of 1,3,3,5,5-penta-methyl-4-oxyl-2-ketopiperazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 13 </heading>
<paragraph id="P-0195" lvl="0"><number>&lsqb;0195&rsqb;</number> Red unscented candle wax is well stabilized by 0.1% by weight of 4,4&prime;-dimethoxy-2,2&prime;-dihydroxybenzophenone in combination with 0.1% by weight of 3,3,4,5,5-pentamethyl-1-(2-hydroxyethyl)piperazin-2-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 14 </heading>
<paragraph id="P-0196" lvl="0"><number>&lsqb;0196&rsqb;</number> Red unscented candle wax is well stabilized by 0.2% by weight of 4-tert-butylphenyl 2-hydroxybenzoate in combination with 0.1% by weight of 3,3,5,5-tetramethyl-4-cyclohexyloxy-1-&lsqb;2-(dodecanoyloxy)ethyl&rsqb;piperazin-2-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 15 </heading>
<paragraph id="P-0197" lvl="0"><number>&lsqb;0197&rsqb;</number> Yellow unscented candle wax is well stabilized by 0.2% by weight of 2-ethoxy-2-ethyl-oxanilide in combination with 0.1% by weight of bis&lsqb;2-(4-cyclohexyloxy-3,3,5,5-tetramethyl-2-ketopiperazin-1-yl)ethyl&rsqb; sebacate. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 16 </heading>
<paragraph id="P-0198" lvl="0"><number>&lsqb;0198&rsqb;</number> Yellow unscented candle wax is well stabilized by 0.2% by weight of 3-hydroxyphenyl benzoate in combination with 0.2% by weight of 4-octyloxy-3,3,5,5-tetramethyl-1-octadecyl-piperazin-2-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 17 </heading>
<paragraph id="P-0199" lvl="0"><number>&lsqb;0199&rsqb;</number> Blue unscented candle wax is well stabilized by 0.2% by weight of dodecyl 3-phenyl-3-methyl-&agr;-cyanoacrylate in combination with 0.1% by weight of 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 18 </heading>
<paragraph id="P-0200" lvl="0"><number>&lsqb;0200&rsqb;</number> Blue unscented candle wax is well stabilized by 0.2% by weight of dodecyl 3,3-diphenyl-&agr;-cyanoacrylate in combination with 0.2% by weight of 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(1,2,2,6,6-pentamethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 19 </heading>
<paragraph id="P-0201" lvl="0"><number>&lsqb;0201&rsqb;</number> Yellow scented candle wax is well stabilized by 0.2% by weight of 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy) carbonyl)ethyl&rsqb;phenyl&rcub;-2H-benzotriazole, TINUVIN&reg; 1130, CIBA, in combination with 2% by weight of 1,2-ethane-bis(3,3,5,5-tetramethyl-piperazin-2-on-1-yl). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 20 </heading>
<paragraph id="P-0202" lvl="0"><number>&lsqb;0202&rsqb;</number> Yellow scented candle wax is well stabilized by 0.1% by weight of 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole, TINUVIN&reg; 928, CIBA, in combination with 0.2% by weight of 7-methyl-7,15-diazadispiro&lsqb;5.1.5.3&rsqb;hexadecane-14-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 21 </heading>
<paragraph id="P-0203" lvl="0"><number>&lsqb;0203&rsqb;</number> Red scented candle wax is well stabilized by 0.1% by weight of 2-(2-hydroxy-5-methyl-phenyl)-2H-benzotriazole, TINUVIN&reg; P, CIBA, in combination with 0.1% by weight of 1,3,3,5,5-pentamethyl-4-(2-hydroxyethyl)-2-ketopiperazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 22 </heading>
<paragraph id="P-0204" lvl="0"><number>&lsqb;0204&rsqb;</number> Green scented candle wax is well stabilized by 0.1% by weight of octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&reg; 384, CIBA, in combination with 0.1% by weight of 3,3,5,5-tetramethyl-4-octyloxy-1-octyl-2-ketopiperazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 23 </heading>
<paragraph id="P-0205" lvl="0"><number>&lsqb;0205&rsqb;</number> Green scented candle wax is well stabilized by 0.1% by weight of octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&reg; 384, CIBA, in combination with 0.1% by weight of 1,3,3,5,5-pentamethyl-4-oxyl-2-ketopiperazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 24 </heading>
<paragraph id="P-0206" lvl="0"><number>&lsqb;0206&rsqb;</number> Blue scented candle wax is well stabilized by 0.1% by weight of 2-(2-hydroxy-5-tert-octylphenyl-2H-benzotriazole, TINUVIN&reg; 329, CIBA, in combination with 0.1% by weight of 3,3,4,5,5-pentamethyl-1-(2-hydroxyethyl)piperazin-2-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 25 </heading>
<paragraph id="P-0207" lvl="0"><number>&lsqb;0207&rsqb;</number> Blue scented candle wax is well stabilized by 0.2% by weight of 4-octyloxy-2-hydroxy-benzophenone in combination with 0.1% by weight of 3,3,5,5-tetramethyl-4-cyclohexyloxy-1-&lsqb;2-(dodecanoyloxy)ethyl&rsqb;piperazin-2-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 26 </heading>
<paragraph id="P-0208" lvl="0"><number>&lsqb;0208&rsqb;</number> Red unscented candle wax is well stabilized by 0.2% by weight of 2-ethylhexyl p-methoxycinnamate in combination with 0.1% by weight of bis&lsqb;2-(4-cyclohexyloxy-3,3,5,5-tetra-methyl-2-ketopiperazin-1-yl)ethyl&rsqb; sebacate. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 27 </heading>
<paragraph id="P-0209" lvl="0"><number>&lsqb;0209&rsqb;</number> Red unscented candle wax is well stabilized by 0.1% by weight of 4,4&prime;-dimethoxy-2,2&prime;dihydroxybenzophenone in combination with 0.1% by weight of 4-octyloxy-3,3,5,5-tetra-methyl-1-octadecylpiperazin-2-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 28 </heading>
<paragraph id="P-0210" lvl="0"><number>&lsqb;0210&rsqb;</number> Yellow unscented candle wax is well stabilized by 0.1% by weight of 2-ethoxy-2&prime;-ethyl-5,4&prime;-di-tert-butyloxanilide in combination with 0.1% by weight of 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 29 </heading>
<paragraph id="P-0211" lvl="0"><number>&lsqb;0211&rsqb;</number> Yellow unscented candle wax is well stabilized by 0.1% by weight of 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)phenyl&rsqb;-s-triazine, TINUVIN&reg; 400, CIBA, in combination with 0.1% by weight of 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(1,2,2,6,6-pentamethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 30 </heading>
<paragraph id="P-0212" lvl="0"><number>&lsqb;0212&rsqb;</number> Blue scented candle wax is well stabilized by 0.1% by weight of 2,4-bis(2,4-dimethyl-phenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)-5-&agr;-cumylphenyl&rsqb;-s-triazine in combination with 0.1% by weight of 1,2-ethane-bis(3,3,5,5-tetramethylpiperazin-2-on-1-yl). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 31 </heading>
<paragraph id="P-0213" lvl="0"><number>&lsqb;0213&rsqb;</number> Blue unscented candle wax is well stabilized by 0.2% by weight of 2,4-bis(2,4-dimethyl-phenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine in combination with 0.1% by weight of 1-acetyl-2,2,6,6-tetramethyl-4,4-(1-oxa-2,4-dioxo-3-dodecyliminotetramethylene)piperidine, TINUVIN&reg; 440, CIBA, and 0.1% by weight of 7-methyl-7,15-diazadispiro&lsqb;5.1.5.3&rsqb;hexadecane-14-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 32 </heading>
<paragraph id="P-0214" lvl="0"><number>&lsqb;0214&rsqb;</number> Blue unscented candle wax is well stabilized by 0.1% by weight of 2,4-bis(2,4-dimethyl-phenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)phenyl&rsqb;-s-triazine, TINUVIN&reg; 400, CIBA, in combination with 0.1% by weight of bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, TINUVIN&reg; 292, CIBA, and 0.1% by weight of 1,3,3,5,5-pentamethyl-4-(2-hydroxyethyl)-2-keto-piperazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 33 </heading>
<paragraph id="P-0215" lvl="0"><number>&lsqb;0215&rsqb;</number> White unscented candle wax is well stabilized by 0.1% by weight of 4-tert-octylphenyl2-hydroxybenzoate in combination with 2% by weight of 3,3,5,5-tetramethyl-4-octyloxy-1-octyl-2-ketopiperazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 34 </heading>
<paragraph id="P-0216" lvl="0"><number>&lsqb;0216&rsqb;</number> White unscented candle wax is well stabilized by 0.1% by weight of 3-hydroxyphenyl benzoate in combination with 0.1% by weight of octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&reg; 384, CIBA, and 0.1% by weight of 1,3,3,5,5-pentamethyl-4-oxyl-2-ketopiperazine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 35 </heading>
<paragraph id="P-0217" lvl="0"><number>&lsqb;0217&rsqb;</number> Yellow scented candle wax is well stabilized by 0.1% by weight of dodecyl 3,3-diphenyl-&agr;-cyanoacrylate in combination with 0.1% by weight of 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)phenyl&rsqb;-s-triazine, TINUVIN&reg; 400, CIBA, and 0.1% by weight of 3,3,4,5,5-pentamethyl-1-(2-hydroxyethyl)piperazin-2-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 36 </heading>
<paragraph id="P-0218" lvl="0"><number>&lsqb;0218&rsqb;</number> Yellow scented candle wax is well stabilized by 0.1% by weight of pentaerythrityl tetrakis&lsqb;3,3-diphenyl-&agr;-cyanoacrylate&rsqb; in combination with 0.2% by weight of 3,3,5,5-tetra-methyl-4-cyclohexyloxy-1-&lsqb;2-(dodecanoyloxy)ethyl&rsqb;piperazin-2-one. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 37 </heading>
<paragraph id="P-0219" lvl="0"><number>&lsqb;0219&rsqb;</number> Red scented candle wax is well stabilized by 0.2% by weight of octyl 3-(p-methoxy-phenyl)-3-phenyl-&agr;-cyanoacrylate in combination with 0.2% by weight of bis&lsqb;2-(4-cyclohexyloxy-3,3,5,5-tetramethyl-2-ketopiperazin-1-yl)ethyl&rsqb; sebacate. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A composition which comprises 
<claim-text>(a) candle wax which is white and unscented; white and scented; dyed and unscented; dyed and scented; dipped and unscented; or dipped and scented, and </claim-text>
<claim-text>(b) an effective stabilizing amount of a combination of 
<claim-text>(i) a piperazinone compound of formula (III) and </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00004">
<number>4</number>
<image id="EMI-C00004" he="119.2968" wi="215.0631" file="US20030000130A1-20030102-C00004.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00004" file="US20030000130A1-20030102-C00004.CDX"/>
<chemistry-mol-file id="CHEMMOL-00004" file="US20030000130A1-20030102-C00004.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>(ii) a UV absorber or an antioxidant, or a UV absorber and an antioxidant </claim-text>
<claim-text>wherein the ratio by weight of (i) to (ii) is from 10:1 to 1:10, and </claim-text>
<claim-text>with the proviso that, when the UV absorber is a benzotriazole, said benzotriazole has only a hydrogen atom at the 5-position of the benzo ring, </claim-text>
<claim-text>wherein </claim-text>
</claim-text>
<claim-text>R<highlight><subscript>1</subscript></highlight>, R<highlight><subscript>2</subscript></highlight>, R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>are independently alkyl of 1 to 12 carbon atoms, said alkyl substituted by one or two hydroxyl groups; or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together or R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>together or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together and R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>together are tetramethylene, pentamethylene or pentamethylene substituted by methyl; </claim-text>
<claim-text>R<highlight><subscript>1</subscript></highlight>&prime;, R<highlight><subscript>2</subscript></highlight>&prime;, R<highlight><subscript>3</subscript></highlight>&prime; and R<highlight><subscript>4</subscript></highlight>&prime; and R<highlight><subscript>1</subscript></highlight>&Prime;, R<highlight><subscript>2</subscript></highlight>&Prime;, R<highlight><subscript>3</subscript></highlight>&Prime; and R<highlight><subscript>4</subscript></highlight>&Prime;are defined as for R<highlight><subscript>1</subscript></highlight>, R<highlight><subscript>2</subscript></highlight>, R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4</subscript></highlight>; </claim-text>
<claim-text>R<highlight><subscript>5 </subscript></highlight>is hydrogen, oxyl, hydroxyl, cyanoethyl, phenylalkyl of 7 to 15 carbon atoms, said phenylalkyl substituted on the phenyl ring by one to three radicals selected from alkyl of 1 to 4 carbon atoms and alkoxy of 1 to 4 carbon atoms, phenylalkoxy of 7 to 15 carbon atoms, said phenylalkoxy substituted on the phenyl ring by one to three radicals selected from alkyl of 1 to 4 carbon atoms and alkoxy of 1 to 4 carbon atoms, cycloalkoxy of 5 to 12 carbon atoms, alkenyl of 3 to 8 carbon atoms, alkynyl of 3 to 8 carbon atoms, alkoxy of 1 to 24 carbon atoms, alkyl of 1 to 24 carbon atoms, said alkyl substituted by one or two hydroxyl groups, said alkyl substituted by alkylcarbonyloxy of 2 to 18 carbon atoms, or said alkyl interrupted by one to twenty oxygen atoms and substituted by one hydroxyl, by alkylcarbonyloxy of 2 to 18 carbon atoms or by 4-hydroxy-3,5-di-tert-butylbenzoyloxy; or R<highlight><subscript>5 </subscript></highlight>is alkanoyl of 1 to 8 carbon atoms, alkenoyl of 3 to 5 carbon atoms, alkanoyloxy of 1 to 18 carbon atoms, glycidyl, or a group &mdash;CH<highlight><subscript>2</subscript></highlight>CH(OH)&mdash;E where E is hydrogen, methyl or phenyl; </claim-text>
<claim-text>R<highlight><subscript>5</subscript></highlight>&prime; and R<highlight><subscript>5</subscript></highlight>&Prime; are defined as for R<highlight><subscript>5</subscript></highlight>; </claim-text>
<claim-text>R<highlight><subscript>6 </subscript></highlight>is alkyl of 1 to 8 carbon atoms, alkanoyl of 1 to 8 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms which is unsubstituted or substituted on the phenyl ring by alkyl of 1 to 4 carbon atoms, by alkoxy or 1 to 4 carbon atoms or by a mixture of said groups; or R<highlight><subscript>6 </subscript></highlight>is alkyl of 1 to 8 carbon atoms or alkanoyl of 1 to 8 carbon atoms substituted by -OH, by alkoxy of 1 to 12 carbon atoms, by benzophenonyl or benzophenonyloxy where one or both phenyl rings of the benzophenone moiety are unsubstituted or substituted by OH, by halogen, by alkyl of 1 to 4 carbon atoms, by alkoxy of 1 to 4 carbon atoms or by a mixture of such groups; and </claim-text>
<claim-text>R<highlight><subscript>6</subscript></highlight>&prime; and R<highlight><subscript>6</subscript></highlight>&Prime; are defined as for R<highlight><subscript>6</subscript></highlight>. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> where in the compound of formula (III), R<highlight><subscript>1</subscript></highlight>, R<highlight><subscript>2</subscript></highlight>, R<highlight><subscript>3</subscript></highlight>, R<highlight><subscript>4</subscript></highlight>, R<highlight><subscript>1</subscript></highlight>&prime;, R<highlight><subscript>2</subscript></highlight>&prime;, R<highlight><subscript>3</subscript></highlight>&prime;, R<highlight><subscript>4</subscript></highlight>&prime;, R<highlight><subscript>1</subscript></highlight>&Prime;, R<highlight><subscript>2</subscript></highlight>&Prime;, R<highlight><subscript>3</subscript></highlight>&Prime; and R<highlight><subscript>4</subscript></highlight>&Prime;are each methyl, or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together and R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>together are pentamethylene or R<highlight><subscript>1</subscript></highlight>&prime; and R<highlight><subscript>2</subscript></highlight>&prime; together and R<highlight><subscript>3</subscript></highlight>&prime; and R<highlight><subscript>4</subscript></highlight>&prime; together are pentamethylene or R<highlight><subscript>1</subscript></highlight>&Prime; and R<highlight><subscript>2</subscript></highlight>&Prime; together and R<highlight><subscript>3</subscript></highlight>&Prime; and R<highlight><subscript>4</subscript></highlight>&Prime; together are pentamethylene. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> where in the compound of formula (III), R<highlight><subscript>5</subscript></highlight>, R<highlight><subscript>5</subscript></highlight>&prime; and R<highlight><subscript>5</subscript></highlight>&Prime; are hydrogen or methyl. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> where in the compound of formula (III), R<highlight><subscript>6</subscript></highlight>, R<highlight><subscript>6</subscript></highlight>&prime; and R<highlight><subscript>6</subscript></highlight>&Prime; are n-butyl or cyclohexyl. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the piperazinone compound of formula (III) is 
<claim-text>(a) 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine or </claim-text>
<claim-text>(b) 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(1,2,2,6,6-pentamethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the ratio by weight of (i) to (ii) is from 4:1 to 1:4. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> wherein the ratio by weight of (i) to (ii) is from 2:1 to 1:2. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the effective amount of the UV absorber plus the piperazinone compound in the candle wax is 0.01 to 10% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00008">claim 8</dependent-claim-reference> wherein the effective amount of the UV absorber plus piperazinone in the candle wax is 0.1 to 2% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> wherein the effective amount of the UV absorber plus piperazinone in the candle wax is 0.1 to 0.5% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the UV absorber of component (ii) is a benzotriazole, a benzophenone, an &agr;-cyanoacrylate, an oxanilide, an s-triazine, a cinnamate, a malonate, a benzoate or a salicylate, or a mixture thereof. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference> wherein the UV absorber is a benzotriazole, a benzophenone or an s-triazine. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference> wherein the UV absorber is 
<claim-text>(a) 4-octyloxy-2-hydroxybenzophenone; </claim-text>
<claim-text>(b) 4-methoxy-2-hydroxybenzophenone; </claim-text>
<claim-text>(c) 2-(2-hydroxy-5-methylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(d) 2-(2-hydroxy-5-tert-octylphenyl-2H-benzotriazole; </claim-text>
<claim-text>(e) 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(f) octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate; </claim-text>
<claim-text>(g) 2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(h) 2-(2-hydroxy-5-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(i) 2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(j) 2-(2-hydroxy-3-tert-butyl-5-methylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(k) 2-(2-hydroxy-3-sec-butyl-5-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(l) 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(m) 2-(2-hydroxy-3-dodecyl-5-methylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(n) 2-&lsqb;2-hydroxy-3,5-di(&agr;,&agr;-dimethylbenzyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(o) 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(p) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)ethyl&rsqb;-phenyl&rcub;-2H-benzotriazole; and </claim-text>
<claim-text>(q) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H- benzotriazole; </claim-text>
<claim-text>(r) 2-ethylhexyl p-methoxycinnamate; </claim-text>
<claim-text>(s) 4-methoxy-2,2&prime;-dihydroxybenzophenone; </claim-text>
<claim-text>(t) 4,4&prime;dimethoxy-2,2&prime;-dihydroxybenzophenone; </claim-text>
<claim-text>(u) 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine; </claim-text>
<claim-text>(v) 2,4-diphenyl-6-(2-hydroxy-4-hexyloxyphenyl)-s-triazine; </claim-text>
<claim-text>(w) 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy) -phenyl&rsqb;-s-triazine; (x) 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxy-propoxy)-5-&agr;-cumylphenyl&rsqb;-s-triazine; </claim-text>
<claim-text>(y) reaction product of 2,4,6-tris(2,4-dihydroxyphenyl)-s-triazine with octyl &agr;-haloacetate; or (z) the mixture of 3,3;3,5;5,5-methylene-bis&lsqb;2,4-bis(2,4-dimethylphenyl)&rsqb;-6-&lsqb;2-hydroxy-4-(3-butyloxy-2-hydroxypropoxyphenyl)&rsqb;-s-triazine. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> wherein the UV absorber is 
<claim-text>(a) 4-octyloxy-2-hydroxybenzophenone; </claim-text>
<claim-text>(b) 4-methoxy-2-hydroxybenzophenone; </claim-text>
<claim-text>(d) 2-(2-hydroxy-5-tert-octylphenyl-2H-benzotriazole; </claim-text>
<claim-text>(o) 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(p) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)ethyl&rsqb;-phenyl&rcub;-2H-benzotriazole; </claim-text>
<claim-text>(q) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H- benzotriazole; </claim-text>
<claim-text>(y) reaction product of 2,4,6-tris(2,4-dihydroxyphenyl)-s-triazine with octyl &agr;-haloacetate; or </claim-text>
<claim-text>(z) the mixture of 3,3;3,5;5,5-methylene-bis&lsqb;2,4-bis(2,4-dimethylphenyl)&rsqb;-6-&lsqb;2-hydroxy-4-(3-butyloxy-2-hydroxypropoxyphenyl)&rsqb;-s-triazine. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the composition contains an antioxidant. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 15</dependent-claim-reference> wherein the antioxidant is a phenolic antioxidant, phosphite, nitrone, amine oxide or hydroxylamine, or mixture thereof. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the effective amount of UV absorber in combination with the piperazinone and an antioxidant is 0.01 to 10% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference> wherein the effective amount of UV absorber in combination with the piperazinone and an antioxidant is 0.1 to 2% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference> wherein the effective amount of UV absorber in combination with the piperazinone and an antioxidant is 0.1 to 0.5% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 15</dependent-claim-reference> wherein the antioxidant is 
<claim-text>n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, </claim-text>
<claim-text>neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinammate), </claim-text>
<claim-text>di-n-octadecyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate, </claim-text>
<claim-text>1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, </claim-text>
<claim-text>thiodiethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </claim-text>
<claim-text>1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, </claim-text>
<claim-text>3,6-dioxaoctamethylene bis(3-methyl-5-tert-butyl-4-hydroxyhydrocinnamate), </claim-text>
<claim-text>2,6-di-tert-butyl-p-cresol, </claim-text>
<claim-text>2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol), </claim-text>
<claim-text>1,3,5-tris(2,6-dimethyl-4-tert-butyl-3-hydroxybenzyl) isocyanurate, </claim-text>
<claim-text>1,1,3,-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane, </claim-text>
<claim-text>1,3,5-tris&lsqb;2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)ethyl&rsqb; isocyanurate, </claim-text>
<claim-text>3,5-di-(3,5-di-tert-butyl-4-hydroxybenzyl)mesitol, </claim-text>
<claim-text>hexamethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </claim-text>
<claim-text>1-(3,5-di-tert-butyl-4-hydroxyanilino)-3,5-di(octylthio)-s-triazine, </claim-text>
<claim-text>N,N&prime;-hexamethylene-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamamide), </claim-text>
<claim-text>calcium bis(ethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate), </claim-text>
<claim-text>ethylene bis&lsqb;3,3-di(3-tert-butyl-4-hydroxyphenyl)butyrate&rsqb;, </claim-text>
<claim-text>octyl 3,5-di-tert-butyl-4-hydroxybenzylmercaptoacetate, </claim-text>
<claim-text>bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazide, </claim-text>
<claim-text>N,N-di-(C<highlight><subscript>14</subscript></highlight>-C<highlight><subscript>24</subscript></highlight>alkyl)-N-methylamine oxide, or </claim-text>
<claim-text>N,N-dialkylhydroxylamine prepared from di(hydrogenated tallow)amine by direct oxidation. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. A composition according to claim <highlight><bold>20</bold></highlight> wherein the antioxidant is 
<claim-text>neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </claim-text>
<claim-text>n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, </claim-text>
<claim-text>1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, </claim-text>
<claim-text>1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, </claim-text>
<claim-text>2,6-di-tert-butyl-p-cresol, or </claim-text>
<claim-text>2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol).</claim-text>
</claim-text>
</claim>
</subdoc-claims>
</patent-application-publication>
